Susquehanna International Group
TTPH

Susquehanna International Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Susquehanna International Group’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,168
Closed -$31K – 11145
2019
Q1 		$31K Sell
1,168
-534
-31% -$13.6K ﹤0.01% 8550
2018
Q4 		$38K Sell
1,702
-7,026
-80% -$275K ﹤0.01% 8564
2018
Q3 		$482K Buy
+8,728
New +$557K ﹤0.01% 6597
2018
Q2 		– Sell
-863
Closed -$60.9K – 10787
2018
Q1 		$53K Sell
863
-68
-7% -$5.97K ﹤0.01% 8937
2017
Q4 		$117K Buy
+931
New +$119K ﹤0.01% 8625
2017
Q1 		– Sell
-3,403
Closed -$381K – 10443
2016
Q4 		$274K Buy
+3,403
New +$269K ﹤0.01% 8143
2016
Q3 		– Sell
-951
Closed -$76.2K – 9333
2016
Q2 		$82K Sell
951
-4,745
-83% -$435K ﹤0.01% 8112
2016
Q1 		$527K Buy
5,696
+1,829
+47% +$183K ﹤0.01% 6315
2015
Q4 		$776K Sell
3,867
-13,903
-78% -$2.77M ﹤0.01% 5933
2015
Q3 		$2.65M Buy
17,770
+13,348
+302% +$9.8M ﹤0.01% 3739
2015
Q2 		$4.2M Buy
4,422
+2,360
+114% +$1.93M ﹤0.01% 3209
2015
Q1 		$1.51M Buy
2,062
+303
+17% +$228K ﹤0.01% 4906
2014
Q4 		$1.4M Buy
1,759
+655
+59% +$353K ﹤0.01% 5180
2014
Q3 		$441K Buy
1,104
+178
+19% +$47.7K ﹤0.01% 7428
2014
Q2 		$250K Buy
926
+74
+9% +$15.9K ﹤0.01% 8691
2014
Q1 		$186K Buy
+852
New +$237K ﹤0.01% 8288
2013
Q3 		– Sell
-542
Closed -$76K – 8926
2013
Q2 		$76K Buy
+542
New +$85.8K ﹤0.01% 7879

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Susquehanna International Group's TTPH Position: Q2 2019 in Review

Susquehanna International Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 1,168 shares — an estimated $31K sold.

Susquehanna International Group first reported a position in TTPH in Q2 2013 and held it in 17 quarters. The position peaked at $4.2M in Q2 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

  • Susquehanna International Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Susquehanna International Group sold 1,168 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $31K.
  • Susquehanna International Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
  • Susquehanna International Group's Tetraphase Pharmaceuticals, Inc. position peaked at $4.2M in Q2 2015.
  • 66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.